Bartneck M, Scheyda KM, Warzecha KT, Rizzo LY, Hittatiya K, Luedde T, Storm G, Trautwein C, Lammers T, Tacke F. Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases. Biomaterials 37, 367-382, 2015.
Shirangi M, Sastre Toraño J, Sellergren B, Hennink WE, Somsen GW, and van Nostrum CF. Bioconjugate Chemistry 26, 90-100, 2015.
Louage B, Zhang Q, Vanparijs N, Voorhaar L, Vande Casteele S, Shi Y, Hennink WE, Van Bocxlaer J, Hoogenboom R, and De Geest BG. Biomacromolecules16, 336-350, 2015.
Novo L, Takeda KM, Petteta T, Dakwar GR, van den Dikkenberg JB, Remaut K, Braeckmans K, van Nostrum CF, Mastrobattista E, and Hennink WE. Molecular Pharmaceutics 12, 150-161, 2015.
Corvo ML, Marinho HS, Marcelino P, Lopes RM, Vale CA, Marques CR, Martins LC, Laverman P, Storm G, and Martins MB. Pharmaceutical Research 32, 91-102, 2015.
Lammers T, Koczera P, Fokong S, Gremse F, Ehling J, Vogt M, Pich A, Storm G, van Zandvoort M, and Kiessling F. Theranastic USPIO-loaded microbubbles for mediating and monitoring blood-brain permeation. Advanced Functional Materials 25, 36-43, 2015.
Kijanka G, Sauerborn M, Boon L, Schellekens H, and Brinks V. Journal of Pharmaceutical Sciences 104, 396-406, 2015.
Oude Blenke E, Klaasse G, Merten H, Plcuckthun A, Mastrobattista E, and Martin NI. Liposome functionalization with copper-free ‘click chemistry’. Journal of Controlled Release 202, 14-20, 2015.
Shi Y, Cardoso RM, van Nostrum CF and Hennink WE. Anthracene functionalized thermosensitive and UV-Crosslinkable polymeric micelles. Polymer Chemistry 6, 2048-2053, 2015.
Oerlemans C, Seevinck PR, Smits ML, Hennink WE, Bakker CJ, van den Bosch MA, and Nijsen JF. International Journal of Pharmaceutics 482, 47-53, 2015.
Kazazi-Hyseni F, Zandstra J, Popa ER, Goldschmeding R, Lathuile AA, Veldhuis GJ, Van Nostrum CF, Hennink WE, and Kok RJ. International Journal of Pharmaceutics 482, 99-109, 2015.
Ramazani F, Chen W, Van Nostrum CF, Storm G, Kiessling F, Lammers T, Hennink WE, and Kok RJ. International Journal of Pharmaceutics 482, 123-130, 2015.
Lammertink B, Deckers R, Storm G, Moonen C, and Bos C. Duration of ultrasound-mediated enhanced plasma membrane permeability. International Journal of Pharmaceutics 482, 92-98, 2015.
Sasaki N, Bos C, Escoffre JM, Storm G, and Moonen C. Development of a tumor tissue mimicking model with endothelial cell layer and collagen gel for evaluating drug penetration. International Journal of Pharmaceutics 482, 118-123, 2015.
Petit A, Redout EM, van de Lest CH, de Grauw JC, Müller B, Meyboom R, van Midwoud P, Vermonden T, Hennink WE, and van Weeren PR. Sustained intra-articular release of celecoxib from in situ forming gels made of acetyl-capped PCLA-PEG-PCLA triblock copolymers in horses. Biomaterials 53, 426-436, 2015.
Hu Q, Rijcken CJ, Banasal R, Hennink WE, Storm G, and Prakash J. Complete regression of breast tumour with a single dose of docetaxel-entrapped core-cross-linked polymeric micelles. Biomaterials 53, 370-378, 2015.
Falke LL, van Vuuren SH, Kazazi-Hyseni F, Ramazani F, Nguyen TQ, Veldhuis GJ, Maarseveen EM, Zandstra J, Zuidema J, Duque LF, Steendam R, Popa ER, Kok RJ, Goldschmeding R. Local therapeutic efficacy with reduced systemic side effects by rapamycin-loaded subcapsular microspheres. Biomaterials 42, 151-160, 2015.
Martens TF, Remaut K, Deschout H, Engbersen JF, Hennink WE, van Steenbergen MJ, Demeester J, De Smedt SC, and Braeckmans K. Journal of Controlled Release 202, 83-92, 2015.
Rahimian S, Fransen MF, Kleinovink JW, Christensen JR, Amidi M, Hennink WE, and Ossendorp F. Polymeric nanoparticles for co-delivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation. Journal of Controlled Release 203, 16-22, 2015.
Fehres CM, Kalay H, Bruijns SCM, Musaafir SAM, Ambrosini M, van Bloois L, van Vliet SJ, Storm G, Garcia-Vallejo JJ, and van Kooyk Y. Cross-presentation through langerin and DC-SIGN targeting requires different formulation of glycan-modified antigens. Journal of Controlled Release 203, 67-76, 2015.
Maas SL, de Vrij J, van der Vlist EJ, Geragousian B, van Bloois L, Mastrobattista E, Schiffelers RM, Wauben MH, Broekman ML, Nolte-'t Hoen EN. Journal of Controlled Release 200, 87-96, 2015.
Schellekens H, and Moors E. Biosimilars or semi-similars? Nature Biotechnology 33, 19-20, 2015.
Kroon J, Buijs JT, van der Horst G, Cheung H, van der Mark M, van Bloois L, Rizzo LY, Lammers T, Pelger RC, Storm G, van der Pluijm G, and Metselaar JM. Prostate 75, 815-824, 2015.
Talelli M, Barz M, Rijcken CF, Kiessling F, Hennink WE, and Lammers T. Core-crosslinked polymeric micelles: principles, preparation, biomedical applications and clinical translation. Nano Today 10, 93-117, 2015.
Hu Q, van Gaal EVB, Brundel P, Ippel H, Hackeng T, Rijcken CJF, Storm G, Hennink WE, and Prakash J. A novel approach for the intravenous delivery of leuprolide using core cross-linked polymeric micelles. Journal of Controlled Release 205, 98-108, 2015.
Shi Y, van der Meel R, Theek B, Oude Blenke E, Pieters EH, Fens MH, Ehling J, Schiffelers RM, Storm G, van Nostrum CF, Lammers T, Hennink WE. ACS Nano 9, 3740-3752, 2015.
Falke L, Gholizadeh Soltani S, Goldschmeding R, Kok RJ, and Nguyen T. Diverse origins of the myofibroblast-implications for kidney fibrosis. Nature Reviews Nephrology 11, 233-244, 2015.
Shi Y, Kunjachan S, Wu Z, Gremse F, Moeckel D, van Zandvoort D, Kiessling F, van Nostrum CF, HenninkWE and Lammers T. Double fluorophore-labeling of core-crosslinked polymeric micelles for multimodal in vivo and ex vivo optical imaging. Nanomedicine 10, 1111-1125, 2015.
Van der Geest T, Metselaar JM, Gerrits D, van Lent PL, Storm G, Laverman P, and Boerman OC. Journal of Controlled Release 209, 20-26, 2015.
Van Meer PJ, Ebbers HC, Kooijman M, Gispen-de Wied CC, Silva-Lima B, Moors EH, and Schellekens H. Drug Discovery Today 20, 483-490, 2015.
Rood J, Nawzad H, Kalicharan R, van Steenbergen M, and Vromans H. Drug release from an oromucosal paste for the selective decontamination of the oropharynx (in ICU patients and healthy volunteers). European Journal of Pharmaceutical Sciences 73, 88-92, 2015.
Smits EA, Soetekouw JA, Bakker PF, Baijens BJ, Vromans H. Journal of Liposome Research 25, 46-57, 2015.
Rahimian S, Fransen MF, Kleinovink JW, Amidi M, Ossendorp F, and Hennink WE. Polymeric microparticles for sustained and local delivery of antiCD40 and antiCTLA-4 in immunotherapy of cancer. Biomaterials 61, 33-40, 2015
Li D, Kordalivand N, Fransen MF,Ossendorp F, Raemdonck K, Vermonden T, Hennink WE, and van Nostrum CF. Reduction-sensitive dextran nanogels aimed for intracellular delivery of antigens. Advanced Functional Materials 25, 2993-3003, 2015.
Kazazi-Hyseni F, van Vuuren SH, van der Giezen DM, Pieters EH, Ramazani F, Rodriguez S, Veldhuis GJ, Goldschmeding R, van Nostrum CF, Hennink WE, and Kok RJ. Release and pharmacokinetics of near-infrared labeled albumin from monodisperse poly(D,L-lactic-co-hydroxymethyl glycolic acid) microspheres after subcapsular renal injection. Acta Biomaterialia 22, 141-154, 2015.
Rad-Malekshahi M, Visscher KM, Rodrigues JP, de Vries R, Hennink WE, Baldus M, Bonvin AM, Mastrobattista E, and Weingarth M. T Journal of the American Chemical Society 137, 7775-7784, 2015.
Shi Y, van Nostrum CF, and Hennink WE. Interfacially hydrazine cross-linked thermosensitive polymeric micelles for acid-triggered release of paclitaxel. ACS Biomaterials Science and Engineering 1, 393-404, 2015.
Vanprijs N, Maji S, Louage B, Voorhaar L, Laplace D, Zhang Q, Shi Y, Hennink WE, Hoogenboom R, De Geest BG. Polymer-protein conjugation via a ‘grafting to’ approach – a comparative study of protein-reactive RAFT chain transfer agents. Polymer Chemistry 6, 5602-5614, 2015.
Shirangi M, Hennink WE, Somsen GW, van Nostrum CF. Pharmaceutical Research 32, 3044-3054, 2015.
Novo L, Mastrobattista E, van Nostrum CF, Lammers T, Hennink WE. Decationized polyplexes for gene delivery. Expert Opinion on Drug Delivery 12, 507-512, 2015.
Naksuriya O, Shi Y, van Nostrum CF Anuchapreeda S, Hennink WE and Okonogi S. HPMA-based polymeric micelles for curcumin solubilization and inhibition of cancer cell growth. European Journal of Pharmaceutics and Biopharmaceutics 94, 501-512, 2015.
Ojha T, Rizzo L, Storm G, Kiessling F, and Lammers T. Image-guided drug delivery: preclinical applications and clinical translation. Expert Opinion on Drug Delivery 12, 1203-1207, 2015.
, , , , , and . Label-free glycoprofiling with multiplex surface plasmon resonance: A tool to quantify sialylation of erythropoietin. Analytical Chemistry 18, 8115-8122, 2015.
Bansal R, Frelin L, Brenndörfer ED, Storm G, Prakash J, and Sällberg M. PLoS One 10(6):e0128466, 2015.
Minghetti P, Rocco P, and Schellekens H. The constrained prescription, interchangeability and substitution of biosimilars. Nature Biotechnology 33, 688-689, 2015.
Boere KWM, van den Dikkenberg J, Gao Y, Visser J, Hennink WE, and Vermonden T. Thermogelling and chemoselectively cross-linked hydrogels with controlled mechanical properties and degradation behavior. Biomacromolecules 16, 2840-2851, 2015.
Rahimian S, Fransen MF, Kleinovink JW, Amidi M, Ossendorp F, and Hennink WE. Particulate systems based on poly(lactic-co-glycolic)acid (pLGA) for immunotherapy of cancer. Current Pharmaceutical Design 21, 2015, 4201-4216.
Kunjachan S, Ehling J, Storm G, Kiessling F, and Lammers T. Chemical Reviews 115, 10907-10937, 2015.
Boks MA, Ambrosini M, Bruijns SC, Kalay H, van Bloois L, Storm G, Garcia-Vallejo JT, and van Kooyk. MPLA incorporation into DC-targeting glycoliposomes favours anti-tumour T cell responses Journal of Controlled Release 216, 37-46, 2015.
Fehres CM, van Beelen AJ, Bruijns SC, Ambrosini M, Kalay H, van Bloois L, Unger WW, Garcia-Vallejo JJ, Storm G, de Gruijl TD, van Kooyk Y. Journal of Investigative Dermatology 135, 2228-2236, 2015.
Lobatto ME, Calcagno C, Otten MJ, Millon A, Ramachandran S, Paridaans MP, van der Valk FM,Storm G, Stroes ES, Fayad ZA, Mulder WJ, and Metselaar JM. Nanomedicine 11, 1133-1140, 2015.
Ramazani F, Hiemstra C, Steendam R, Kazazi-Hyseni F, Van Nostrum CF, Storm G, Kiessling F, Lammers T, Hennink WE, Kok RJ. European Journal of Pharmaceutics and Biopharmaceutics 95, 368-375, 2015.
Van den Biggelaar M, Madsen JJ, Faber JH, Zuurveld MG, van der Zwaan C, Olsen OH, Stennicke HR, Mertens K, an Meijer AB. Journal of Biological Chemistry 290, 16463-16476, 2015.
Bloem E, Ebberink EH, van den Biggelaar M, van der Zwaan C, Mertens K, Meijer AB. Biochemical Journal 468, 65-72, 2015.
Van Elk, Lorenzato C, Ozbakir B, Oerlemans C, Storm G, Nijsen F, Deckers R, Vermonden T, and Hennink WE. European Polymer Journal 72, 620-631, 2015.
Vermonden T, and Klumperman B. The past, present and future of hydrogels. European Polymer Journal 72, 341-343, 2015.
Dubbini A, Censi R, Butini ME, Sabbieti MG, Agas D, Tina Vermonden, and Piera Di Martino. . European Polymer Journal 72, 423-437, 2015.
Van Elk M, Ozbakir B, Barten-Rijbroek AD, Storm G, Nijsen F, Hennink WE, Vermonden T and Deckers R. Alginate microspheres containing temperature sensitive liposomes (TSL) for MR-guided embolization and triggered release of doxorubicin. PLoS ONE 10(11), e0141626, 2015.
Dolman ME, Poon E, Ebus ME, den Hartog IJ, van Noesel CJ, Jamin Y, Hallsworth A, Robinson SP, Petrie K, Sparidans RW, Kok RJ, Versteeg R, Caron HN, Chesler L, and Molenaar JJ. Clinical Cancer Research 21, 5100-5109, 2015.
Van der Geest T, Laverman P, Gerrits D, Franssen GM, Metselaar JM, Storm G, and Boerman OC. C Journal of Controlled Release 220, 239-244, 2015.
Underwood C, Pollitt CC, Metselaar JM, Laverman P, van Bloois L, van den Hoven JM, Storm G, and van Eps AW. Veterinary Journal 206, 218-225, 2015.
Schellekens H, Lietzan E, Faccin F, and Venema J. Expert Opinion Biological Therapy 15, 1633-1646, 2015.
Boere KWM, Blokzijl MM, Visser K, Linssen EA Malda J, Hennink WE and Vermonden R. Biofabrication of reinforced 3D-scaffolds using two-component hydrogels. Journal of Materials Chemistry B. 3, 9067-7078, 2015.
Kroon J, Puhr M, Buijs JT, van der Horst G, Hemmer DM, Marijt KA, Hwang MS, Masood M, Grimm S, Storm G, Metselaar JM, Meijer OC, Culig Z, van der Pluijm G. Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer. Endocr Relat Cancer. 2016; 23(1): 35-45.
Van der Valk FM, van Wijk DF, Lobatto ME, Verberne HJ, Storm G, Willems MC, Legemate DA, Nederveen AJ, Calcagno C, Mani V, Ramachandran S, Paridaans MP, Otten MJ, Dallinga-Thie GM, Fayad ZA, Nieuwdorp M, Schulte DM, Metselaar JM, Mulder WJ, Stroes ES. Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration. Nanomedicine. 2015; 11(5): 1039-1046.
Bansal R, Van Baarlen J, Storm G, Prakash J. The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis. Scientific Reports 2015; 5, 18272; doi: 10.1038/srep18272 (2015). (IF2014: 5.58)
Boks MA, Bruijns SC, Ambrosini M, Kalay H, van Bloois L, Storm G, Gruijl Td, van Kooyk Y. In situ delivery of tumor antigen- and adjuvant-loaded liposomes boosts antigen-apecific T-Cell responses by human dermal dendritic cells. J Invest Dermatol. 2015 Nov;135(11):2697-704
Negussie AH, Dreher MR, Johnson CG, Tang Y, Lewis AL, Storm G, Sharma KV, Wood BJ. Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization. J Mater Sci Mater Med. 2015 Jun;26(6):198.
Duinhouwer, L. E., Tüysüz, N., Rombouts, E. W., Ter Borg, M. N., Mastrobattista, E., Spanholtz, J., ... & Braakman, E. (2015). Wnt3a Protein Reduces Growth Factor-Driven Expansion of Human Hematopoietic Stem and Progenitor Cells in Serum-Free Cultures. PloS one, 10(3).
Elevated urinary CTGF in diabetic nephropathy is caused by local production and tubular dysfunction. Gerritsen KG, Leeuwis JW, Koeners MP, Bakker SJ, van Oeveren W, Aten J, Tarnow L, Rossing P, Wetzels JF, Joles JA, Kok RJ, Goldschmeding R, Nguyen TQ. Journal of Diabetes Research 2015, 2015:539787.
